News
-
-
PRESS RELEASE
Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
Mainz Biomed N.V. to present results of pancreatic cancer verification study at AACR 2026 Annual Meeting in San Diego, showcasing blood-based mRNA signature for PDAC detection and IPMN differentiation -
-
-
-
-
-
PRESS RELEASE
Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America
Mainz Biomed and OncoVanguard8 partner to introduce ColoAlert DNA-based colorectal cancer screening test to South America, starting with Peru, in a strategic move to enhance early detection and public health outcomes -
-